Aniracetam restores motivation reduced by satiation in a choice reaction task in aged rats

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 1, 2001, Pages 65-69

  Nakamura, Kazuo ^a   Kurasawa, Mitsue ^a  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

Aged rats; Aniracetam; Attention and vigilance; Choice reaction task; Motivation; Satiation

Indexed keywords

ANIRACETAM; 2 PYRROLIDONE DERIVATIVE; NOOTROPIC AGENT;

ACCURACY; AGED; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DECISION MAKING; DRUG EFFECT; IMPULSIVENESS; MALE; MOTIVATION; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RESPONSE TIME; SATIETY; TASK PERFORMANCE; VELOCITY; AGING; ANIMAL; AROUSAL; DIET RESTRICTION; DOSE RESPONSE; INSTRUMENTAL CONDITIONING; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; PSYCHOPHYSIOLOGY; RAT STRAIN; REACTION TIME;

ANIMALIA;

AGING; ANIMAL; AROUSAL; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; MALE; MOTIVATION; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE; PYRROLIDINONES; RATS; RATS, WISTAR; REACTION TIME; SATIETY RESPONSE;

EID: 0035080987     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00440-8     Document Type: Article

References (23)

1. Potentiating action of the cerebral insufficiency enhancer, aniracetam, on adenosine triphosphate production in rat brain mitochondria
2. General pharmacological properties of aniracetam, a cerebral insufficiency improver
3. Treatment of Parkinson's disease with aniracetam
4. Spontaneity in dementia: An analysis of 696 institutionalized elderly patients
5. Treatment of insomnia by concomitant therapy with zopiclone and aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease
6. Effects of aniracetam on impaired sleep patterns in stroke-prone spontaneously hypertensive rats
7. Anxiolytic, anti-impulsive and antidepressive properties of aniracetam in rodents
8. Usefulness of aniracetam for the mental symptoms of chronic cerebral infarction (Second report). Assessment with the GBS and Hamilton Rating Scales
9. Pharmacology of aniracetam: A novel pyrrolidinone derivative with cognition enhancing activity
10. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam
11. Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam
12. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam
13. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam
14. Impulsivity and AMPA receptors: Aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats
15. Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders: Double-blind trial in placebo
16. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells
17. Physical consequences of depression in the stroke patient
18. Dementia following stroke
19. Clinical experience with aniracetam in the treatment of senile dementia of the Alzheimer's type and related disorders
20. Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S, 3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP
21. 2 receptor-mediated head-twitch response in rodents as a hallucination model
22. Recovery of diminished mealtime-associated anticipatory behavior by aniracetam in aged rats
23. Learning readiness for patients teaching in stroke rehabilitation